Showing results (401-410 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|July 1, 1996
Antiemetic treatment with two different doses of methylprednisolone in breast cancer patients: a double-blind randomized cross-over study with evaluation of efficacy parametersH Havsteen, M Kjaer
Anti-Cancer Drugs|July 1, 1996
Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulatorsT Shirasaka, Y Shimamato, H Ohshimo, et al.
Anti-Cancer Drugs|July 1, 1996
A quantitative morphometric study of the kinetics of tissue regeneration after administration of cisplatinJ Sela, J Shani, S Borut-Mintz, et al.
Anti-Cancer Drugs|July 1, 1996
The influence of hypoxia on the cytotoxicity of concomitant KW-2149 and ionizing irradiation in Chinese hamster fibroblastsA Egelmeers, L Y Dirix, J Lyczek, et al.
Anti-Cancer Drugs|July 1, 1996
Antineoplastic activities of 2,3,4-chloro-substituted beta-alkylaminopropiophenone derivatives in CF1 mice and in murine and human tumor cellsY Huang, I H Hall
Anti-Cancer Drugs|May 4, 2010
Epigenetic tools in potential anticancer therapyKatarina Sebova, Ivana Fridrichova
Anti-Cancer Drugs|September 4, 2008
Effects, in an in-vivo model system, of 1,2,3,4-tetrahydroisoquinoline on gliomaGyong-Suk Kang, Xiang Di Wang, Michael L Mohler, et al.
Anti-Cancer Drugs|September 4, 2008
Efficacy of doxifluridine combined with weekly paclitaxel therapy in the treatment of advanced or recurrent breast cancer: results of the JMTO BC01 phase II trialReiki Nishimura, Takeshi Tominaga, Morihiko Kimura, et al.
Anti-Cancer Drugs|April 20, 2010
Emergent toxicities associated with the use of mTOR inhibitors in patients with advanced renal carcinomaJesus Rodriguez-Pascual, Elaine Cheng, Pablo Maroto, et al.
Anti-Cancer Drugs|August 24, 2006
Severe enteropathy associated with raltitrexed and oxaliplatin chemotherapy: report of two patients experiencing this rare, potentially lethal gastrointestinal adverse eventCatharina Wenzel, Eleonora Urbauer, Christoph Schwarz, et al.
Pageof 464